ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/12/12 | 2,019 | 2,024 | 1,995 | 1,998 | -22 | -1.1% | 49,700 |
2023/12/11 | 2,001 | 2,020 | 2,001 | 2,020 | +19 | +0.9% | 53,100 |
2023/12/08 | 2,022 | 2,022 | 1,991 | 2,001 | -11 | -0.5% | 99,900 |
2023/12/07 | 2,045 | 2,053 | 2,012 | 2,012 | -33 | -1.6% | 70,100 |
2023/12/06 | 2,024 | 2,049 | 2,020 | 2,045 | +23 | +1.1% | 65,900 |
2023/12/05 | 2,038 | 2,047 | 2,019 | 2,022 | -11 | -0.5% | 67,600 |
2023/12/04 | 2,040 | 2,043 | 2,015 | 2,033 | -11 | -0.5% | 73,500 |
2023/12/01 | 2,036 | 2,057 | 2,034 | 2,044 | +18 | +0.9% | 95,900 |
2023/11/30 | 2,017 | 2,032 | 2,001 | 2,026 | +12 | +0.6% | 100,700 |
2023/11/29 | 2,009 | 2,018 | 1,995 | 2,014 | +21 | +1.1% | 98,600 |
2023/11/28 | 1,970 | 1,994 | 1,958 | 1,993 | +23 | +1.2% | 74,800 |
2023/11/27 | 1,995 | 1,995 | 1,966 | 1,970 | -5 | -0.3% | 58,000 |
2023/11/24 | 1,973 | 1,975 | 1,955 | 1,975 | +22 | +1.1% | 70,700 |
2023/11/22 | 1,942 | 1,965 | 1,942 | 1,953 | +11 | +0.6% | 79,000 |
2023/11/21 | 1,923 | 1,944 | 1,918 | 1,942 | +21 | +1.1% | 69,500 |
2023/11/20 | 1,944 | 1,953 | 1,918 | 1,921 | -15 | -0.8% | 93,800 |
2023/11/17 | 1,917 | 1,936 | 1,907 | 1,936 | +32 | +1.7% | 80,700 |
2023/11/16 | 1,902 | 1,924 | 1,896 | 1,904 | +2 | +0.1% | 98,900 |
2023/11/15 | 1,907 | 1,913 | 1,886 | 1,902 | +7 | +0.4% | 86,900 |
2023/11/14 | 1,889 | 1,907 | 1,881 | 1,895 | +6 | +0.3% | 78,200 |
2023/11/13 | 1,920 | 1,920 | 1,880 | 1,889 | -18 | -0.9% | 101,400 |
2023/11/10 | 1,891 | 1,907 | 1,881 | 1,907 | +4 | +0.2% | 102,400 |
2023/11/09 | 1,916 | 1,919 | 1,885 | 1,903 | -7 | -0.4% | 128,700 |
2023/11/08 | 1,934 | 1,936 | 1,894 | 1,910 | -12 | -0.6% | 188,300 |
2023/11/07 | 1,945 | 1,957 | 1,920 | 1,922 | -25 | -1.3% | 130,200 |
2023/11/06 | 1,999 | 2,000 | 1,945 | 1,947 | -21 | -1.1% | 169,600 |
2023/11/02 | 1,946 | 1,983 | 1,912 | 1,968 | -80 | -3.9% | 264,400 |
2023/11/01 | 2,011 | 2,050 | 2,008 | 2,048 | +52 | +2.6% | 170,900 |
2023/10/31 | 1,970 | 1,998 | 1,967 | 1,996 | +34 | +1.7% | 118,500 |
2023/10/30 | 1,991 | 1,991 | 1,951 | 1,962 | -49 | -2.4% | 122,700 |
2023/10/27 | 1,987 | 2,011 | 1,970 | 2,011 | +48 | +2.4% | 70,800 |
2023/10/26 | 1,990 | 2,002 | 1,963 | 1,963 | -16 | -0.8% | 108,100 |
2023/10/25 | 1,999 | 1,999 | 1,977 | 1,979 | -8 | -0.4% | 108,200 |
2023/10/24 | 2,000 | 2,008 | 1,954 | 1,987 | -8 | -0.4% | 102,800 |
2023/10/23 | 1,989 | 2,017 | 1,988 | 1,995 | -13 | -0.6% | 145,400 |
2023/10/20 | 1,989 | 2,017 | 1,982 | 2,008 | -1 | ±0% | 121,200 |
2023/10/19 | 2,018 | 2,040 | 2,009 | 2,009 | -33 | -1.6% | 102,200 |
2023/10/18 | 2,025 | 2,050 | 2,003 | 2,042 | +22 | +1.1% | 102,500 |
2023/10/17 | 2,021 | 2,045 | 2,015 | 2,020 | -22 | -1.1% | 156,300 |
2023/10/16 | 2,058 | 2,060 | 2,021 | 2,042 | -16 | -0.8% | 75,900 |
2023/10/13 | 2,094 | 2,094 | 2,056 | 2,058 | -56 | -2.6% | 98,400 |
2023/10/12 | 2,123 | 2,135 | 2,111 | 2,114 | -6 | -0.3% | 58,400 |
2023/10/11 | 2,144 | 2,150 | 2,120 | 2,120 | -24 | -1.1% | 52,200 |
2023/10/10 | 2,117 | 2,152 | 2,112 | 2,144 | +7 | +0.3% | 126,300 |
2023/10/06 | 2,116 | 2,158 | 2,113 | 2,137 | +40 | +1.9% | 117,500 |
2023/10/05 | 2,081 | 2,108 | 2,077 | 2,097 | -4 | -0.2% | 162,900 |
2023/10/04 | 2,110 | 2,142 | 2,073 | 2,101 | -18 | -0.8% | 102,900 |
2023/10/03 | 2,170 | 2,179 | 2,119 | 2,119 | -55 | -2.5% | 116,000 |
2023/10/02 | 2,202 | 2,228 | 2,174 | 2,174 | -45 | -2% | 135,400 |
2023/09/29 | 2,235 | 2,235 | 2,205 | 2,219 | -20 | -0.9% | 100,200 |
101~
150
件表示中 / 3454件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 204,500円 | +9.6% | +17.5% | 2.25% | 11.56倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,000円 | +7.3% | +16.8% | 3.05% | 23.51倍 | 0.92倍 |
|
JT傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗HIV薬の販売権喪失が直撃 |
杏林製薬 | 172,000円 | +3.2% | +4.5% | 3.02% | 19.76倍 | 0.76倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 217,000円 | +7.6% | +57.5% | 2.44% | 16.76倍 | 1.65倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割弱。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 64,000円 | -3.7% | -36.7% | 3.13% | 21.59倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム